\begin{tabular}{llll}
\toprule
Biomarker & AUC & Source & Advantage \\
\midrule
PD-L1 Expression (CD274) & 0.572 & This study (GSE91061) & Baseline comparator \\
TMB (â‰¥10 mut/Mb) & 0.60-0.65* & Samstein 2019 (literature) & Requires WES/WGS \\
MSI-H Status & 0.70-0.80* & Le et al. 2015 (literature) & Limited to MMR-deficient tumors \\
Our Pathway Composite (8 pathways) & 0.779 & This study (GSE91061) & RNA-seq only, multi-pathway, validated \\
\bottomrule
\end{tabular}
